Ludwig Boltzmann Institute
Hematology and Oncology

Welcome
to the Ludwig Boltzmann Institute for Hematology and Oncology (LBI HO)
The overarching goal of the Ludwig Boltzmann Institute for Hematology and Oncology (formerly Ludwig Boltzmann Cluster Oncology (LBC ONC)) is to develop new therapeutic concepts in cancer research aiming at eliminating cancer stem cells in leukemias and solid tumors.
The individual tasks are derived from the successful collaboration of preclinical basic research and clinical medicine in the field of tumor stem cell research.
Molecular cell and tissue research results are being implemented in the development of new strategies for cancer and leukemia treatment.
The research objectives are determined by new concepts for clinical applications that are the outcome of results from our in vitro– studies.
News
-
Evaluation 2021
On November 10th and 11th, 2021, the performance of the Ludwig Boltzmann Institute for Hematology…
LBI für Hämatologie und Onkologie
17 Jun 2022
-
Scientific Advisory Board Meeting 2019
On Friday, November 8th, 2019 the annual Scientific Advisory Board (SAB) of the LBI HO took place…
LBI für Hämatologie und Onkologie
02 Dec 2019 -
Thomas Grunt received Asclepius-Award
Thomas Grunt, Deputy Scientific Coordinator of the LBI HO, is Principal Investigator of an award-…
LBI für Hämatologie und Onkologie
14 Nov 2019 -
Austrian Society for Stem Cell Research founded
On March 20, 2018 the Austrian Society for Stem Cell Research (ASSCR.at) was founded, with the go…
LBI für Hämatologie und Onkologie
22 Mar 2018 -
LBI HO Contribution to the Blue Book of the WHO
The latest edition of the Blue Book of the WHO, titled the ‘Classification of Tumours of Haematop…
LBI für Hämatologie und Onkologie
03 Oct 2017 -
LBC ONC at the Oral Health Research Congress
Prof. Peter Valent had the honor to give the Robert Frank Lecture during the opening ceremony of …
LBI für Hämatologie und Onkologie
21 Sep 2017
-
Evaluation 2021
On November 10th and 11th, 2021, the performance of the Ludwig Boltzmann Institute for Hematology…
LBI für Hämatologie und Onkologie
17 Jun 2022 -
Scientific Advisory Board Meeting 2019
On Friday, November 8th, 2019 the annual Scientific Advisory Board (SAB) of the LBI HO took place…
LBI für Hämatologie und Onkologie
02 Dec 2019 -
Thomas Grunt received Asclepius-Award
Thomas Grunt, Deputy Scientific Coordinator of the LBI HO, is Principal Investigator of an award-…
LBI für Hämatologie und Onkologie
14 Nov 2019 -
Austrian Society for Stem Cell Research founded
On March 20, 2018 the Austrian Society for Stem Cell Research (ASSCR.at) was founded, with the go…
LBI für Hämatologie und Onkologie
22 Mar 2018 -
LBI HO Contribution to the Blue Book of the WHO
The latest edition of the Blue Book of the WHO, titled the ‘Classification of Tumours of Haematop…
LBI für Hämatologie und Onkologie
03 Oct 2017 -
LBC ONC at the Oral Health Research Congress
Prof. Peter Valent had the honor to give the Robert Frank Lecture during the opening ceremony of …
LBI für Hämatologie und Onkologie
21 Sep 2017